An Evaluation of the Erchonia Corporation GVS Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity on the Abdominal Region
Erchonia Corporation
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® GVS in improving the appearance of skin laxity on the abdominal region.
Description
This clinical study is a prospective open-label design with post-study independent blinded outcome analysis to evaluate the efficacy of the Erchonia® GVS Laser in improving the appearance of skin laxity on the abdominal region. Participants will receive 8 treatments over the course of 4 weeks.
Eligibility
- Age range
- 22–70 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Subject has signed a written informed consent form. * Male or female 22 to 70 years of age, inclusive. * Desire to undergo treatment for skin laxity of the abdomen. * Subject's score on the skin laxity scale for skin on the abdomen is 1 (mild) or 2 (moderate). * Subject agrees to maintain his/her weight (i.e., within 5%) by not making any major changes in diet, exercise or medication routine during the course of the study. * Subject agrees to refrain from taking any medication(s) or supplements(s), whether prescription or OTC, or undergo any procedures indicated for weig…
Interventions
- DeviceErchonia GVS Laser
405nm violet and 520nm green laser light therapy.
Location
- Cesar A. Lara M.D. Weight Loss & WellnessDunedin, Florida